相关实验视频

Updated: Jan 8, 2026

Methods for In Vivo Biomechanical Testing on Brachial Plexus in Neonatal Piglets

Methods for In Vivo Biomechanical Testing on Brachial Plexus in Neonatal Piglets

Published on: December 19, 2019

在臂阻塞中的:一个元分析,元回归和试验顺序分析

Sushil Pal¹, Rasmeet Kaur Kainth², Rajiv Malhotra³

¹ST5 Resident Doctor, Department of Anaesthesia, Royal Liverpool University Hospital, UK.

Indian journal of anaesthesia

|December 15, 2025

概括

硫酸 (MgSO4) 加快了手臂结块 (BPBs) 的感觉阻断的发生. 它还延长了缓解疼痛的持续时间,剂量为200毫克或更少的剂量在长时间的止痛中显得最有效.

科学领域:

麻醉学麻醉学
药理学药理学是指药理学的学科.

背景情况:

硫酸 (MgSO4) 在加速手臂阻塞 (BPBs) 的感觉阻塞发作中的有效性仍在争论中.
这一元分析研究了MgSO4作为BPB局部麻醉剂 (LA) 的辅助剂的影响.

研究的目的:

评估将MgSO4添加到LA对BPB感官阻塞发病时间的影响.
评估二次结果,包括感觉和运动阻断的持续时间,以及镇痛的持续时间.

主要方法:

随机临床试验的系统元分析,将MgSO4与BPB中的对照进行比较.
搜索包括Medline,Embase,谷歌学者和书目.
主要结局:感官阻断的发生. 二次结果:阻塞持续时间和镇痛持续时间. 使用随机效应模型和按MgSO4剂量进行亚组分析.

主要成果:

SO4显著加快了感官阻断 (SMD = -1.00) 和运动阻断 (SMD = -1.15) 的开始.
MgSO4延长了镇痛效应的持续时间 (SMD = 4.22).
较高的MgSO4剂量 (>200毫克) 与较低的剂量 (≤200毫克) 相比,显示了延长的感觉和运动阻断持续时间和更长的止痛.

结论:

在BPB中将MgSO4添加到LA中,导致感官阻塞的更快发作.
此外,MgSO4还可以增强镇痛的持续时间,剂量≤200毫克可能提供最佳效益.

关键词:

止痛药止痛药是一种止痛药.臂状交叉 (Brachial Plexus) 是一个神经系统.局部麻醉剂局部麻醉剂硫酸硫酸是一种这是一个元分析.这是一种元回归 (meta-regression).这是一种神经障碍,神经障碍.区域麻醉地区麻醉区域性镇痛镇痛区域性镇痛

更多相关视频

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

相关概念视频

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...

Classification of Skeletal Muscle Relaxants

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...